Clinical Trial Update: The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

This document provides a status update on a Phase 2 safety and dose-range study of Metacavir Enteric-coated Capsules in patients with Chronic Hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Metacavir Enteric-coated Capsules (metacavir)

Snippet

Sponsor: Guangzhou Yipinhong Pharmaceutical CO.,LTD | Conditions: Chronic Hepatitis B | Phase 2 | Status: UNKNOWN